Fred Hutch study discovers rare set of cells that are highly effective at fighting cancer


The discovery and the new tech will be important for scientists developing CAR-T immunotherapies, treatments that reprogram a person’s T-cells to fight cancer. The tech was developed by Seattle-based Adaptive Biotechnologies, and it assigns a “barcode” to each T-cell based on the kind of T-cell receptor (TCR) it has. This …